المؤلفون: Jan van den Brande, Tessa Uiterwaal, Christianne J. Buskens, Juda Vecht, Robert E G J M Pierik, Job H.C. Peters, Nofel Mahmmod, John Maring, E. Joline de Groof, Toer W. Stevens, H. B. A. C. Stockmann, Pieter C. F. Stokkers, Karlien F. Bruin, Eric J. Hazebroek, Ailsa Hart, Arnold van de Laar, Hubert A Prins, Richard van Hillegersberg, Rachel L. West, Paul Kingma, Menno A. Brink, Pritesh Morar, Ruud Schouten, Marno C.M. Rijk, A Jeroen de Groof, Sijbrand Hofker, Annekatrien Depla, Bregje Mol, Janneke van der Woude, T. J. Gardenbroek, Janindra Warusavitarne, Bas Oldenburg, Edwin S. van der Zaag, Anna A. W. van Geloven, Rogier M P H Crolla, Emma J. Eshuis, Hans Brouwer, Meindert N. Sosef, Maria L Haasnoot, Geert R. D'Haens, Nynke Talstra, Marcel Spanier, Liekele Oostenbrug, Jeroen M. Jansen, Maarten J Boom, Donald L. van der Peet, Nanne K. H. de Boer, Willem A. Bemelman, Cyriel Y. Ponsioen, Rosalie C Mallant, Theo J.M. van Ditzhuijsen, Gerard Dijkstra, Alexander P.J. Houdijk, Willem A. Marsman, Djuna Cahen, Casper G. Noomen, Huib A. Cense, Esther C. J. Consten, Michael F. Gerhards, Ad A. van Bodegraven, Rob J. Lieverse, Andreas Marinelli, Sjoerd van der Werff, Clemens Bolwerk, Ernst Jan Spillenaar Bilgen, Quirijn A. J. Eijsbouts, Guido Mannaerts, Bart A. van Wagensveld

المساهمون: ​Robotics and image-guided minimally-invasive surgery (ROBOTICS), Gastroenterology and hepatology, Surgery, AGEM - Digestive immunity, AII - Inflammatory diseases, Graduate School, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, Gastroenterology and Hepatology, Paediatric Surgery

المصدر: The lancet. Gastroenterology & hepatology, 5(10), 900-907. HANLEY & BELFUS-ELSEVIER INC
LIR!C study group 2020, ' Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease : retrospective long-term follow-up of the LIR!C trial ', The Lancet Gastroenterology and Hepatology, vol. 5, no. 10, pp. 900-907 . https://doi.org/10.1016/S2468-1253(20)30117-5
The Lancet Gastroenterology and Hepatology, 5(10), 900-907. Elsevier Ltd
lancet. Gastroenterology & hepatology, 5(10), 900-907. Elsevier Limited

مصطلحات موضوعية: Male, Cost-Benefit Analysis, Disease, Crohn Disease/etiology, law.invention, Laparoscopy/methods, 0302 clinical medicine, Crohn Disease, Quality of life, Randomized controlled trial, Adrenal Cortex Hormones, law, Cost-Benefit Analysis/methods, Cecum, Crohn's disease, Hazard ratio, Gastroenterology, Middle Aged, Immunologic Factors/therapeutic use, Treatment Outcome, 030220 oncology & carcinogenesis, Gastrointestinal Agents/therapeutic use, Female, 030211 gastroenterology & hepatology, medicine.drug, Adult, medicine.medical_specialty, Terminal Ileitis, Adrenal Cortex Hormones/therapeutic use, Cecum/pathology, 03 medical and health sciences, Gastrointestinal Agents, Ileum, medicine, Immunologic Factors, Humans, Retrospective Studies, Hepatology, Tumor Necrosis Factor-alpha, Tumor Necrosis Factor-alpha/antagonists & inhibitors, business.industry, Retrospective cohort study, medicine.disease, Ileum/pathology, Infliximab, Surgery, Infliximab/therapeutic use, Quality of Life, Laparoscopy, business, Follow-Up Studies

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e5752a7757a14a7ceff01b5b9c7a95a
https://doi.org/10.1016/s2468-1253(20)30117-5

المؤلفون: Kennedy, Nicholas A, Goodhand, James R, Bewshea, Claire, Nice, Rachel, Chee, Desmond, Lin, Simeng, Chanchlani, Neil, Butterworth, Jeffrey, Cooney, Rachel, Croft, Nicholas M, Hart, Ailsa L, Irving, Peter M, Kok, Klaartje B, Lamb, Christopher A, Limdi, Jimmy K, Macdonald, Jonathan, McGovern, Dermot Pb, Mehta, Shameer J, Murray, Charles D, Patel, Kamal V, Pollok, Richard Cg, Raine, Timothy, Russell, Richard K, Selinger, Christian P, Smith, Philip J, Bowden, Jack, McDonald, Timothy J, Lees, Charlie W, Sebastian, Shaji, Powell, Nicholas, Ahmad, Tariq, Contributors To The CLARITY IBD Study

المساهمون: Imperial College Healthcare NHS Trust- BRC Funding, Kennedy, Nicholas A [0000-0003-4368-1961], Goodhand, James R [0000-0003-3112-376X], Bewshea, Claire [0000-0002-0965-9587], Chee, Desmond [0000-0003-3473-9447], Lin, Simeng [0000-0002-4201-4879], Chanchlani, Neil [0000-0003-0207-6706], Cooney, Rachel [0000-0003-3710-157X], Croft, Nicholas M [0000-0002-1519-6435], Hart, Ailsa L [0000-0002-7141-6076], Irving, Peter M [0000-0003-0972-8148], Kok, Klaartje B [0000-0002-5942-9149], Lamb, Christopher A [0000-0002-7271-4956], Limdi, Jimmy K [0000-0002-1039-6251], McGovern, Dermot Pb [0000-0001-5621-759X], Mehta, Shameer J [0000-0002-7002-293X], Murray, Charles D [0000-0001-6736-1546], Patel, Kamal V [0000-0003-2611-4260], Pollok, Richard Cg [0000-0001-6452-6763], Raine, Timothy [0000-0002-5855-9873], Russell, Richard K [0000-0001-7398-4926], Selinger, Christian P [0000-0003-2022-5859], Smith, Philip J [0000-0003-1568-3978], Bowden, Jack [0000-0003-2628-3304], McDonald, Timothy J [0000-0003-3559-6660], Lees, Charlie W [0000-0002-0732-8215], Sebastian, Shaji [0000-0002-3670-6545], Powell, Nicholas [0000-0003-3231-6950], Ahmad, Tariq [0000-0002-6058-5528], Apollo - University of Cambridge Repository

المصدر: 2021, ' Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab ', Gut, vol. 70, no. 5, pp. 865-875 . https://doi.org/10.1136/gutjnl-2021-324388
Gut

مصطلحات موضوعية: 0301 basic medicine, Adult, Male, Antibody Formation/immunology, Principal–agent problem, inflammatory diseases, autoimmune disease, Antibodies, Monoclonal, Humanized, Antibodies, Viral, SARS-CoV-2/immunology, Cohort Studies, 03 medical and health sciences, 0302 clinical medicine, Gastrointestinal Agents, inflammatory bowel disease, Inflammatory Bowel Diseases/drug therapy, Economics, Humans, clarity, Serologic Tests, Antibodies, Viral/immunology, Prospective Studies, vedoluzimab, COVID-19/epidemiology, Poverty, Gastroenterology & Hepatology, SARS-CoV-2, United Kingdom/epidemiology, Gastroenterology, COVID-19, 1103 Clinical Sciences, Neoclassical economics, Middle Aged, Inflammatory Bowel Diseases, Bounded rationality, United Kingdom, Contributors to the CLARITY IBD study, Infliximab/therapeutic use, 030104 developmental biology, Antibodies, Monoclonal, Humanized/therapeutic use, Antibody Formation, Gastrointestinal Agents/therapeutic use, 1114 Paediatrics and Reproductive Medicine, 030211 gastroenterology & hepatology, Female, infliximab

وصف الملف: application/pdf; application/vnd.openxmlformats-officedocument.wordprocessingml.document; text/xml

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b6e01dd054652cb9b8697520d2d594a
https://hdl.handle.net/20.500.11820/1bfd49d0-2ff9-4251-9b80-3c64409dface

المؤلفون: Caroline Trang, Salima Hacein-Bey Abina, Malin Ryner, Florian Deisenhammer, Manuel Comabella, Abiba Doukani, Philippe Broët, Anna Fogdell-Hahn, Julianne Duhaze, Hans-Peter Hartung, Clemens Warnke, Natacha Szely, Delphine Bachelet, Alessandra Vultaggio, Bernd C. Kieseier, Sebastian Spindeldreher, Olivier Brocq, Poul Erik Hyldgaard-Jensen, Michael Auer, Marc Pallardy, Matthieu Allez, Mary Birchler, Tom W J Huizinga, Yehuda Chowers, Yoram Bouhnik, Dorothea Buck-Martin, Elizabeth C. Jury, Amy Loercher, Dan Sikkema, Aude Gleizes, Tobias Derfuss, Jessica J Manson, Guillaume Cadiot, Claudia Sievers, Michael Khalil, Naoimh Donnellan, Raija L.P. Lindberg, Agnès Hincelin Mery, Badreddine Mohand Oumoussa, Enrico Maggi, Martin Soubrier, Kathleen Ingenhoven, Orhan Aktas, Sophie Tourdot, Xavier Montalban, Maria Nachury, Niek de Vries, Timothy P. Hickling, Christophe Richez, Bernhard Hemmer, Franck Carbonnel, Finn Sellebjerg, Jérôme Avouac, Petra Nytrova, Xavier Mariette, Anna Lauren, Signe Hässler, Pierre Dönnes, Eva Havrdova, Michael Guger, Claudia Mauri

المساهمون: BRUNEL, Nadège, Centre de recherche en épidémiologie et santé des populations (CESP), Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay, Immunologie - Immunopathologie - Immunothérapie [CHU Pitié Salpêtrière] (I3), CHU Charles Foix [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Sorbonne Université (SU), Institut de médecine et d'épidémiologie appliquée [AP-HP Hôpital Bichat-Claude Bernard] (IMEA), AP-HP - Hôpital Bichat - Claude Bernard [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), CHU Sainte Justine [Montréal], Université Paris-Saclay, AP-HP Hôpital Bicêtre (Le Kremlin-Bicêtre), Unité de Technologies Chimiques et Biologiques pour la Santé (UTCBS - UM 4 (UMR 8258 / U1022)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité), Heinrich Heine Universität Düsseldorf = Heinrich Heine University [Düsseldorf], Innsbruck Medical University = Medizinische Universität Innsbruck (IMU), Université Paris Cité - UFR Médecine [Santé] (UPCité UFR Médecine), Université Paris Cité (UPCité), GlaxoSmithKline, Glaxo Smith Kline, Hôpital Beaujon, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Hôpital Princesse Grace [Monaco], Technische Universität Munchen - Université Technique de Munich [Munich, Allemagne] (TUM), Hôpital universitaire Robert Debré [Reims], University of Haifa [Haifa], Universitat Autònoma de Barcelona (UAB), University Hospital Basel [Basel], VU University Medical Center [Amsterdam], Royal Berkshire Hospital, Plateforme Post-génomique de la Pitié-Salpêtrière (PASS-P3S), Unité Mixte de Service Production et Analyse de données en Sciences de la vie et en Santé (PASS), Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU), Kepler University Hospital, University Hospital Düsseldorf, Charles University [Prague] (CU), Leiden University Medical Center (LUMC), Rigshospitalet [Copenhagen], Copenhagen University Hospital, University College of London [London] (UCL), Karl-Franzens-Universität Graz, Malmö Högskola = Malmö University, University of Basel (Unibas), Università degli Studi di Firenze = University of Florence (UniFI), University College London Hospitals (UCLH), Service des Maladies de l'Appareil Digestif et de la Nutrition [CHRU Lille], Hôpital Claude Huriez [Lille], CHU Lille-CHU Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), CHU de Bordeaux Pellegrin [Bordeaux], Karolinska Institutet [Stockholm], CHU Clermont-Ferrand, Université de Florence, Fachhochschule Köln, University of Skövde [Sweden], Pfizer, SANOFI Recherche, Hopital Saint-Louis [AP-HP] (AP-HP), Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Institut de Chimie du CNRS (INC)-Université de Paris (UP)-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM), University of Dusseldorf, Innsbruck Medical University [Austria] (IMU), Université de Paris - UFR Médecine Paris Centre [Santé] (UP Médecine Paris Centre), Université de Paris (UP), Sorbonne Université (SU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Karl-Franzens-Universität [Graz, Autriche], Malmø University, Università degli Studi di Firenze = University of Florence [Firenze] (UNIFI), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS)-Université de Paris (UP), University of Graz, AII - Inflammatory diseases, Clinical Immunology and Rheumatology

المصدر: Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
PLoS Medicine
PLoS Medicine, 17(10). PUBLIC LIBRARY SCIENCE
PLoS Medicine, 2020, 17 (10), pp.e1003348. ⟨10.1371/journal.pmed.1003348⟩
Hässler, S, Bachelet, D, Duhaze, J, Szely, N, Gleizes, A, Hacein-Bey Abina, S, Aktas, O, Auer, M, Avouac, J, Birchler, M, Bouhnik, Y, Brocq, O, Buck-Martin, D, Cadiot, G, Carbonnel, F, Chowers, Y, Comabella, M, Derfuss, T, De Vries, N, Donnellan, N, Doukani, A, Guger, M, Hartung, H-P, Kubala Havrdova, E, Hemmer, B, Huizinga, T, Ingenhoven, K, Hyldgaard-Jensen, P E, Jury, E C, Khalil, M, Kieseier, B, Laurén, A, Lindberg, R, Loercher, A, Maggi, E, Manson, J, Mauri, C, Mohand Oumoussa, B, Montalban, X, Nachury, M, Nytrova, P, Richez, C, Ryner, M, Sellebjerg, F, Sievers, C, Sikkema, D, Soubrier, M, Tourdot, S, Trang, C, Vultaggio, A & ABIRISK Consortium 2020, ' Clinicogenomic factors of biotherapy immunogenicity in autoimmune disease : A prospective multicohort study of the ABIRISK consortium ', PLoS Medicine, vol. 17, no. 10, e1003348 . https://doi.org/10.1371/journal.pmed.1003348
PLoS Medicine, Public Library of Science, 2020, 17 (10), pp.e1003348. ⟨10.1371/journal.pmed.1003348⟩
PLoS Medicine, Vol 17, Iss 10, p e1003348 (2020)
PLoS medicine, 17(10):e1003348. Public Library of Science

مصطلحات موضوعية: Male, Physiology, [SDV]Life Sciences [q-bio], Single Nucleotide Polymorphisms, Autoimmune Diseases/drug therapy, Biological Therapy/methods, Arthritis, 030204 cardiovascular system & hematology, Biochemistry, Inflammatory bowel disease, Etanercept, Arthritis, Rheumatoid, Cohort Studies, chemistry.chemical_compound, Medical Conditions, 0302 clinical medicine, Crohn Disease, Antibiotics, Immune Physiology, Medicine and Health Sciences, Prospective Studies, 030212 general & internal medicine, ComputingMilieux_MISCELLANEOUS, Immune System Proteins, Antimicrobials, Drugs, Neurodegenerative Diseases, General Medicine, Middle Aged, 3. Good health, [SDV] Life Sciences [q-bio], Biological Therapy, Antibodies, Monoclonal, Humanized/therapeutic use, Neurology, Arthritis, Rheumatoid/drug therapy, Rheumatoid arthritis, Genome-Wide Association Study/methods, Medicine, [SDV.IMM]Life Sciences [q-bio]/Immunology, Female, Rituximab, Immunosuppressive Agents, Interferon beta-1a, Research Article, medicine.drug, Adult, Multiple Sclerosis, [SDV.IMM] Life Sciences [q-bio]/Immunology, Immunology, Rheumatoid Arthritis, Gastroenterology and Hepatology, Antibodies, Monoclonal, Humanized, Microbiology, Antibodies, HLA-DQ alpha-Chains, Autoimmune Diseases, 03 medical and health sciences, Tocilizumab, Rheumatology, Adalimumab/therapeutic use, Microbial Control, HLA-DQ alpha-Chains/genetics, Rituximab/therapeutic use, Genetics, medicine, Adalimumab, Humans, Antigens, Biological Products/immunology, Pharmacology, Biological Products, Interferon beta-1a/therapeutic use, business.industry, Inflammatory Bowel Disease, Biology and Life Sciences, Proteins, medicine.disease, Demyelinating Disorders, Infliximab, Minor allele frequency, Infliximab/therapeutic use, chemistry, Crohn Disease/drug therapy, Immunosuppressive Agents/therapeutic use, Multiple Sclerosis/drug therapy, Clinical Immunology, Colitis, Ulcerative, Clinical Medicine, Colitis, Ulcerative/drug therapy, business, Genome-Wide Association Study

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f38afd466f71b9ab3ba9e7e10f54091
https://doi.org/10.1371/journal.pmed.1003348

المؤلفون: Alexander A. Navarini, Curdin Conrad, Alessio Mylonas, Anne-Karine Lapointe, Jeremy Di Domizio, Olivier Demaria, Michel Gilliet, Cyrine Belkhodja, Lars E. French, Maxime Vernez

المساهمون: University of Zurich, Conrad, Curdin

المصدر: Nature Communications, Vol 9, Iss 1, Pp 1-11 (2018)
Nature Communications
Nature communications, vol. 9, no. 1, pp. 25

مصطلحات موضوعية: 0301 basic medicine, Male, T-Lymphocytes, General Physics and Astronomy, Autoimmunity, medicine.disease_cause, 030207 dermatology & venereal diseases, 0302 clinical medicine, Crohn Disease, Interferon, lcsh:Science, Cells, Cultured, Mice, Inbred BALB C, Multidisciplinary, 10177 Dermatology Clinic, Antibodies, Monoclonal, Middle Aged, 3100 General Physics and Astronomy, Adalimumab/adverse effects, Adalimumab/immunology, Adalimumab/therapeutic use, Adolescent, Adult, Aged, Animals, Antibodies, Monoclonal/adverse effects, Antibodies, Monoclonal/immunology, Antibodies, Monoclonal/therapeutic use, Autoimmunity/drug effects, Autoimmunity/immunology, Crohn Disease/drug therapy, Crohn Disease/immunology, Crohn Disease/metabolism, Cytokines/genetics, Cytokines/immunology, Cytokines/metabolism, Dendritic Cells/drug effects, Dendritic Cells/immunology, Dendritic Cells/metabolism, Female, Humans, Infliximab/adverse effects, Infliximab/immunology, Infliximab/therapeutic use, Interferon Type I/genetics, Interferon Type I/immunology, Interferon Type I/metabolism, Psoriasis/chemically induced, Psoriasis/immunology, T-Lymphocytes/drug effects, T-Lymphocytes/immunology, T-Lymphocytes/metabolism, Tumor Necrosis Factor-alpha/antagonists & inhibitors, Tumor Necrosis Factor-alpha/immunology, Tumor Necrosis Factor-alpha/metabolism, Young Adult, Interferon Type I, Cytokines, Tumor necrosis factor alpha, medicine.drug, Science, 610 Medicine & health, 1600 General Chemistry, General Biochemistry, Genetics and Molecular Biology, Article, 03 medical and health sciences, 1300 General Biochemistry, Genetics and Molecular Biology, Psoriasis, medicine, Adalimumab, business.industry, Tumor Necrosis Factor-alpha, General Chemistry, Dendritic Cells, medicine.disease, Type I interferon production, Infliximab, 030104 developmental biology, Immunology, lcsh:Q, business, Interferon type I

وصف الملف: application/pdf; 2018_LF_TNF_blockade_induces_a_dysregulated_type_I_interferon_response_without_autoimmunity_in_paradoxical_psoriasis.pdf - application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbbc7decb248c10970a313c075620f0f
https://doaj.org/article/180fc992d72e4fcbbf1d606055e86015

المؤلفون: V Pereira, Ricardo Figueira, C.S.C.R. Andrade, Goreti Faria, Luís Jasmins

المصدر: Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
GE-Portuguese Journal of Gastroenterology v.24 n.2 2017
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Agência para a Sociedade do Conhecimento (UMIC)-FCT-Sociedade da Informação

مصطلحات موضوعية: musculoskeletal diseases, medicine.medical_specialty, Anti-nuclear antibody, Doenças inflamatórias intestinais, tratamento, Lupus erythematosus, systemic/chemically induced, Gastroenterology, Lupus eritematoso, sistémico/induzido quimicamente, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Inflammatory bowel diseases, drug therapy, skin and connective tissue diseases, Proctitis, General Environmental Science, 030203 arthritis & rheumatology, Lupus erythematosus, Systemic lupus erythematosus, medicine.diagnostic_test, business.industry, Infliximab, therapeutic use, Hydroxychloroquine, medicine.disease, Rash, Clinical Case Study, Infliximab, Surgery, Factor de necrose tumoral alfa, uso terapêutico, Erythrocyte sedimentation rate, General Earth and Planetary Sciences, 030211 gastroenterology & hepatology, Infliximab, uso terapêutico, medicine.symptom, Tumor necrosis factor alpha, therapeutic use, business, medicine.drug

وصف الملف: text/html

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22ae4d46090d38082d050e29f779cd88
https://doi.org/10.1159/000450877

المؤلفون: Jaime Ramos, Joana Roseira

المصدر: Acta Médica Portuguesa, Vol 32, Iss 4, Pp 305-312 (2019)
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Agência para a Sociedade do Conhecimento (UMIC)-FCT-Sociedade da Informação
instacron:RCAAP

مصطلحات موضوعية: Certolizumab Pegol / therapeutic use, Adalimumab / pharmacokinetics, Placenta, Anti-Inflammatory Agents, lcsh:Medicine, Pregnancy Complications / drug therapy, Disease, Adrenal Cortex Hormones / therapeutic use, Inflammatory bowel disease, Infliximab / pharmacokinetics, Antibodies, Monoclonal / therapeutic use, 0302 clinical medicine, Certolizumab Pegol / pharmacokinetics, Adrenal Cortex Hormones, Pregnancy, Adalimumab / therapeutic use, Maternal-Fetal Exchange, Placenta / metabolism, lcsh:R5-920, Anti-Inflammatory Agents / therapeutic use, Tumor Necrosis Factor-alpha / antagonists & inhibitors, Antibodies, Monoclonal, General Medicine, Anti-Inflammatory Agents / pharmacokinetics, medicine.anatomical_structure, 030220 oncology & carcinogenesis, Practice Guidelines as Topic, Gestation, 030211 gastroenterology & hepatology, Female, Pregnancy Trimesters, lcsh:Medicine (General), medicine.drug, Adrenal Cortex Hormones / pharmacokinetics, medicine.medical_specialty, Inflammatory Bowel Diseases / drug therapy, Adrenal Cortex Hormones / adverse effects, 03 medical and health sciences, Internal medicine, medicine, Adalimumab, Humans, Infliximab / therapeutic use, Fetus, Tumor Necrosis Factor-alpha, business.industry, Inflammatory Bowel Disease, lcsh:R, Inflammatory Bowel Diseases, medicine.disease, Antibodies, Monoclonal / pharmacokinetics, Infliximab, CHLC GAS, Pregnancy Complications, Pregnancy Trimesters / metabolism, Certolizumab Pegol, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::586e07d2a85c618ef8ffd90a3b25f0ff
https://hdl.handle.net/10400.17/3271

المؤلفون: Philip G Conaghan, J. Andrews, Edith Villeneuve, Helen Keen, Ann W. Morgan, Agata Burska, Paul Emery, Jacqueline L Nam, Lukasz Kozera, Elizabeth M A Hensor, Lesley-Anne Bissell, Maya H Buch, Sarah L. Mackie, Helena Donica

المصدر: Bissell, L-A, Hensor, E M A, Kozera, L, Mackie, S L, Burska, A N, Nam, J L, Keen, H, Villeneuve, E, Donica, H, Buch, M H, Conaghan, P G, Andrews, J, Emery, P & Morgan, A W 2016, ' Improvement in insulin resistance is greater when infliximab is added to methotrexate during intensive treatment of early rheumatoid arthritis-results from the IDEA study ', Rheumatology (Oxford, England), vol. 55, no. 12, pp. 2181-2190 . https://doi.org/10.1093/rheumatology/kew306

مصطلحات موضوعية: Blood Glucose, Glucocorticoids/therapeutic use, Male, Peptide Fragments/metabolism, medicine.medical_treatment, Aftercare, Antirheumatic Agents/therapeutic use, 030204 cardiovascular system & hematology, Biomarkers/metabolism, Cholesterol, HDL/metabolism, Gastroenterology, Lipid Metabolism/drug effects, Arthritis, Rheumatoid, 0302 clinical medicine, Risk Factors, Surveys and Questionnaires, Natriuretic Peptide, Brain, Insulin, Pharmacology (medical), Cardiovascular Diseases/diagnosis, Middle Aged, Treatment Outcome, Methylprednisolone, Cardiovascular Diseases, Arthritis, Rheumatoid/drug therapy, Rheumatoid arthritis, Antirheumatic Agents, Female, Glucocorticoid, hormones, hormone substitutes, and hormone antagonists, medicine.drug, Adult, medicine.medical_specialty, Insulin/metabolism, Methotrexate/therapeutic use, Diabetes Complications, 03 medical and health sciences, Young Adult, Insulin resistance, Blood Glucose/drug effects, Rheumatology, Double-Blind Method, Internal medicine, medicine, Natriuretic Peptide, Brain/metabolism, Humans, Methylprednisolone/therapeutic use, Glucocorticoids, Aged, 030203 arthritis & rheumatology, business.industry, Cholesterol, HDL, Diabetes Complications/complications, medicine.disease, Lipid Metabolism, Infliximab, Peptide Fragments, Infliximab/therapeutic use, Endocrinology, Methotrexate, Early Diagnosis, Insulin Resistance, business, Body mass index, Insulin Resistance/physiology, Biomarkers

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce739f2e682ae2bf4a0028c1cce9920a
https://www.research.manchester.ac.uk/portal/en/publications/improvement-in-insulin-resistance-is-greater-when-infliximab-is-added-to-methotrexate-during-intensive-treatment-of-early-rheumatoid-arthritisresults-from-the-idea-study(128006b9-7d3e-4ebc-b0e5-fa80cef85189).html